BioTalk with Rich Bendis Podcast Kinexum’s Dr. Zan Fleming, M.D. and Thomas Seoh join Rich Bendis on BioTalk Dr. Zan Fleming, M.D. and Thomas Seoh of Kinexum join Biotalk host Rich Bendis to discuss the company, Metabesity, and…Super UserSeptember 9, 2019
News The Link Between Drug Prices and Research on the Next Generation of Cures | ITIF Congress and the Trump administration are considering proposals to reduce the price of drugs, but there is a strong causal…Super UserSeptember 9, 2019
News Hard to Find Small Lab Space! 708 Quince Orchard Road, Gaithersburg, Maryland Three move-in ready laboratory/office modules; each approximately 1,200 RSF with communal services and amenities…Super UserSeptember 9, 2019
News 10 Takeover Targets to Watch This Fall Viewed simply by dollar value, the value of mergers-and-acquisitions (M&A) activity appeared to be zooming in the first half of…Super UserSeptember 9, 2019
News What if aging weren’t inevitable, but a curable disease? – MIT Technology Review Each Cyclops had a single eye because, legend has it, the mythical giants traded the other one with the god…Super UserSeptember 9, 2019
News 2 new unicorns, over $550 million in funding, in Bay Area at end of week – Silicon Valley Business Journal Two more Bay Area companies hit unicorn valuations of $1 billion or more at the end of the week as…Super UserSeptember 9, 2019
News Viela Bio Announces Publication in The Lancet of Pivotal Study Results of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder | Business Wire Viela Bio today announced that peer-reviewed journal, The Lancet, has published results from its pivotal study of inebilizumab in patients…Super UserSeptember 9, 2019
News PeopleOnTheMove – September 2019 – BioBuzz There were 5 New Hires and Promotions in the #BioHealthCapitalRegion in the month of August! Check out all the #PeopleOnTheMove…Super UserSeptember 9, 2019
News Frederick biotech Veralox Therapeutics raises $5.4M to support drug development, trials – Baltimore Business Journal Veralox specializes in developing drugs to address unmet medical needs. It is currently working on therapies to target type 1…Super UserSeptember 9, 2019
News Here are the six winners of Johnson & Johnson’s innovation challenge – Ventureburn Healthcare giant Johnson & Johnson today announced the six winners of the Champions of Science Africa Innovation Challenge 2.0 at…Super UserSeptember 9, 2019